Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (IgG-Fv) (BSGV-H288)

Recombinant Anti-CD32B x Anti-CD79B Bispecific Antibody (IgG-Fv) is formed by an Immunoglobulin G (IgG) and a fragment variable Fv region, in which the Fc of IgG is engineered by KIH. The Fv region of an anti-CD32B antibody variable domain is fused to the C terminal of an IgG of anti-CD79B antibody, or vice versa. The format retains desired characteristics of intact antibodies. This BsAb can regulate B-cell modulation. It is designed for the research of Immune diseases therapy.

Datasheet

Specifications

Targets

CD32B & CD79B

Type

IgG-Fv

Species Reactivity

Human

Target 1

CD32B

Host Animal 1

Mouse

Target 2

CD79B

Host Animal 2

Mouse

Application

FuncS; Promising therapeutic agent

Related Disease

Immune diseases

Targets

Target 1

CD32B

Gene ID

2213

UniProt ID

P31994

Alternative Names

FCGR2B; Fc fragment of IgG, low affinity IIb, receptor (CD32); FcγRIIB; CD32; FCG2; CD32B; FCGR2; IGFR2; low affinity immunoglobulin gamma Fc region receptor II-b; CDw32; fcRII-b; Fc gamma RIIb; fc-gamma-RIIb; fc-gamma RII-b; igG Fc receptor II-b; Fc fragment of IgG, low affinity II, receptor for (CD32); Fc fragment of IgG, low affinity IIb, receptor for (CD32)

Target 2

CD79B

Gene ID

974

UniProt ID

P40259

Alternative Names

CD79B; CD79b molecule, immunoglobulin-associated beta; Cluster of differentiation 79B; CD79b antigen; B29; IGB; AGM6; B-cell antigen receptor complex-associated protein beta chain; Ig-beta; B-cell-specific glycoprotein B29; immunoglobulin-associated B29 protein; CD79b antigen (immunoglobulin-associated beta); immunoglobulin-associated CD79 beta

Welcome! For price inquiries, we will get back to you as soon as possible.

To order, please email

INQUIRY

Online Inquiry

USA
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email:

Europe
Heidenkampsweg 58, 20097 Hamburg, Germany
Tel: 44-207-097-1828
Email: